PROM1 and neoplasm: Despite the lack of specific cellular entity of CD133+ cells, their rarity and functional diversity in the peripheral blood argues for the use of RT-PCR assays as primary means of detection which hold certain advantages over flow cytometry or circulating tumor cell technology.